07/27/2012
Tesfaldet T. Michael, MD, MPH; Donald Haagen, RCIS, MD; Tayo Addo, MD; Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Arif Mahmood, MD; Subhash Banerjee, MD, FSCAI; Aristotelis C. Papayannis, MD; Dinara Yangirova, MD; Abdul-Rahman Abdel-Karim, MD; Michele Roesle, RN, BSN, MD; Julia Kohlhaas, MD; Bavana V. Rangan, BDS, MPH, MD; Lorenza Makke, MD
Abstract: Objectives. The Stenting of Saphenous Grafts-Xience V (SOS-Xience V) trial prospectively examined the frequency of angiographic in-stent restenosis in saphenous vein graft (SVG) lesions 12 months after implantation of a Xience V...
Abstract: Objectives. The Stenting of Saphenous Grafts-Xience V (SOS-Xience V) trial prospectively examined the frequency of angiographic in-stent restenosis in saphenous vein graft (SVG) lesions 12 months after implantation of a Xience V...
Abstract: Objectives. The...